OneSource Specialty Pharma Reports 109% Profit Growth and 37% Revenue Rise in Q2 FY27
OneSource Specialty Pharma reported a 109% year-on-year increase in adjusted net profit to Rs 93.7 crore for Q2 FY27, driven by higher volumes from new drug-device combination capacity, strong execution of manufacturing service agreements, and multiple product launches. Revenue grew 37% year-on-year to Rs 516 crore, with EBITDA rising 53% and margins expanding to 31.6%. The company commercialized a second cartridge production line and plans to triple capacity by FY28, expecting further growth in the second half of the fiscal year.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (75/100). Lens Score 36/100.
Outlets measured: moneycontrol, freepressjournal. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (75–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
freepressjournal broke this story on 27 Oct, 07:11 am. Other outlets followed.